Clinical Trial Update: A Phase I Study Evaluating Autologous Bone Marrow Derived Mesenchymal Stromal for Crohn's Disease. [Phase 1]

View source ↗

Summary

Phase I study evaluating autologous bone marrow-derived mesenchymal stromal cells for Crohn's disease has completed. The trial is sponsored by Emory University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stromal cells (mesenchymal stromal cells)

Snippet

Sponsor: Emory University | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED